Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Dishman Carbogen Amcis Ltd

DCAL.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: N/A

Last Close

$2.00

▼ -3.95%

Market Cap $313.20M · Vol 232.00K

Key Metrics

P/E Ratio

30.70

FWD: N/A

Market Cap

$313.20M

Small Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

54.33

Momentum

Beta

1.63

vs Market

52W High

$3.37

44.91% below

52W Low

$1.35

46.68% above

Volume

232.00K

Avg 253.24K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

30.70%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Dishman Carbogen Amcis Ltd (DCAL.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DCAL.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.23%

-2.20%

+7.34%

-5.49%

YTD

-22.99%

-28.75%

+5.06%

-7.56%

Financials & Valuation

TTM · Annual

Total Revenue	$313.72M
Net Income	$10.43M
Revenue Growth (YoY)	-90.17%
Gross Margin	74.65%
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	0.96% · N/A

P/E Ratio	30.70
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	156.78M

Technical Indicators

50-Day SMA	$1.95
200-Day SMA	$2.13
RSI (14)	54.33
Beta	1.63
52-Week High	$3.37
52-Week Low	$1.35

Volume Today	232.00K
Avg Daily Volume (30D)	253.24K
Relative Volume	0.92x
Volatility (10D)	38.78
Volatility (30D)	32.16
Free Float	30.70%

Analyst Consensus

N/A

Current Price $2.00

Mean Target N/A

52W Low$1.35 52W High$3.37

Current

Target

$1.35 $3.37

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG00GTVQMR8

ISININE385W01011

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS) and the manufacture and supply of marketable molecules such as specialty chemicals, vitamins and chemicals, and disinfectants. Its segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. The Marketable Molecules segment manufactures and supplies intermediates, quaternary compounds, specialty chemicals, and various products for pharmaceuticals and cosmetics. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom, and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., and others.